Affordable Access

deepdyve-link
Publisher Website

Efficacy of Angiotensin-Converting Enzyme Inhibitors and Angiotensin-Receptor Blockers in Coronary Artery Disease without Heart Failure in the Modern Statin Era: a Meta-Analysis of Randomized-Controlled Trials.

Authors
  • Hoang, Vu1
  • Alam, Mahboob2
  • Addison, Daniel2
  • Macedo, Francisco2
  • Virani, Salim3
  • Birnbaum, Yochai2
  • 1 Department of Internal Medicine, Division of Cardiology, Baylor College of Medicine, Faculty Center, One Baylor Plaza MS: BCM 620, Houston, TX, 77030, USA. [email protected]
  • 2 Department of Internal Medicine, Division of Cardiology, Baylor College of Medicine, Faculty Center, One Baylor Plaza MS: BCM 620, Houston, TX, 77030, USA.
  • 3 Michael E. DeBakey Veterans Affairs Medical Center Health Services Research and Development and Section of Cardiology, Department of Internal Medicine, Baylor College of Medicine, Houston, TX, USA.
Type
Published Article
Journal
Cardiovascular drugs and therapy
Publication Date
Apr 01, 2016
Volume
30
Issue
2
Pages
189–198
Identifiers
DOI: 10.1007/s10557-016-6652-7
PMID: 26861251
Source
Medline
Keywords
License
Unknown

Abstract

In CAD patients without HF, ACEi, but not ARBs decreases the risk of non-fatal MI, cardiovascular mortality and all-cause mortality, while both ACEi and ARBs decrease the risk of stroke.

Report this publication

Statistics

Seen <100 times